Chinese General Practice ›› 2024, Vol. 27 ›› Issue (21): 2623-2629.DOI: 10.12114/j.issn.1007-9572.2023.0691
• Original Research·Thyroid Disease Section • Previous Articles Next Articles
Received:
2023-07-31
Revised:
2024-02-21
Published:
2024-07-20
Online:
2024-04-18
Contact:
XU Yun
通讯作者:
许云
作者简介:
作者贡献:
谷珊珊负责研究资料的收集和整理,进行统计学分析并绘制图表,论文构思和原稿撰写;付力、王晶惠、郭欣煜参与文章构思与设计、数据收集与管理;许云负责论文修订、质量控制及审校,对论文整体负责。
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0691
一般资料 | 例数 | 百分比(%) | 一般资料 | 例数 | 百分比(%) |
---|---|---|---|---|---|
性别 | 瘤体状态 | ||||
女 | 74 | 46.5 | 无瘤生存 | 50 | 31.4 |
男 | 85 | 53.5 | 带瘤生存 | 109 | 68.6 |
年龄 | 复发转移 | ||||
<30岁 | 1 | 0.6 | 无 | 71 | 44.7 |
30~50岁 | 26 | 16.4 | 有 | 88 | 55.3 |
51~70岁 | 91 | 57.2 | 复发转移数目 | ||
71~90岁 | 41 | 25.8 | 局部复发 | 40 | 45.5 |
BMI | 寡转移 | 38 | 43.2 | ||
<18.5 kg/m2 | 12 | 7.5 | ≥2个部位 | 10 | 11.4 |
18.5~23.9 kg/m2 | 84 | 52.8 | 转移年限 | ||
24.0~27.9 kg/m2 | 57 | 35.8 | <1年 | 48 | 58.5 |
≥28.0 kg/m2 | 6 | 3.8 | 1~3年 | 25 | 30.5 |
运动习惯 | >3年 | 9 | 11.0 | ||
<3次/周 | 6 | 3.8 | 目前分期 | ||
≥3次/周 | 100 | 62.9 | 早中期 | 64 | 40.3 |
不规律 | 33 | 20.8 | 晚期 | 91 | 57.2 |
从不运动 | 20 | 12.6 | 未知 | 4 | 2.5 |
婚姻 | 疾病治疗阶段 | ||||
无配偶 | 15 | 9.4 | 确诊未治疗 | 9 | 5.7 |
有配偶 | 144 | 90.6 | 围西医治疗期 | 127 | 79.8 |
肿瘤种类 | 随访期 | 23 | 14.5 | ||
肺癌 | 50 | 31.4 | 既往是否抗肿瘤治疗 | ||
乳腺癌 | 23 | 14.5 | 是 | 101 | 63.5 |
头颈部肿瘤 | 21 | 13.2 | 否 | 58 | 36.5 |
直肠癌 | 21 | 13.2 | 目前主要治疗方式 | ||
结肠癌 | 18 | 11.3 | 无 | 6 | 3.8 |
妇科肿瘤 | 9 | 5.7 | 化疗 | 57 | 35.8 |
胃癌 | 6 | 3.8 | 放疗 | 20 | 12.6 |
食管癌 | 3 | 1.9 | 靶向 | 12 | 7.5 |
肝癌 | 2 | 1.3 | 中医药治疗 | 64 | 40.3 |
胰腺癌 | 2 | 1.3 | KPS | ||
其他 | 4 | 2.4 | ≥80分 | 120 | 75.5 |
确诊年限 | <80分 | 39 | 24.5 | ||
<1年 | 81 | 50.9 | |||
1~3年 | 40 | 25.2 | |||
>3年 | 38 | 23.9 |
Table 1 General information of CRF patients
一般资料 | 例数 | 百分比(%) | 一般资料 | 例数 | 百分比(%) |
---|---|---|---|---|---|
性别 | 瘤体状态 | ||||
女 | 74 | 46.5 | 无瘤生存 | 50 | 31.4 |
男 | 85 | 53.5 | 带瘤生存 | 109 | 68.6 |
年龄 | 复发转移 | ||||
<30岁 | 1 | 0.6 | 无 | 71 | 44.7 |
30~50岁 | 26 | 16.4 | 有 | 88 | 55.3 |
51~70岁 | 91 | 57.2 | 复发转移数目 | ||
71~90岁 | 41 | 25.8 | 局部复发 | 40 | 45.5 |
BMI | 寡转移 | 38 | 43.2 | ||
<18.5 kg/m2 | 12 | 7.5 | ≥2个部位 | 10 | 11.4 |
18.5~23.9 kg/m2 | 84 | 52.8 | 转移年限 | ||
24.0~27.9 kg/m2 | 57 | 35.8 | <1年 | 48 | 58.5 |
≥28.0 kg/m2 | 6 | 3.8 | 1~3年 | 25 | 30.5 |
运动习惯 | >3年 | 9 | 11.0 | ||
<3次/周 | 6 | 3.8 | 目前分期 | ||
≥3次/周 | 100 | 62.9 | 早中期 | 64 | 40.3 |
不规律 | 33 | 20.8 | 晚期 | 91 | 57.2 |
从不运动 | 20 | 12.6 | 未知 | 4 | 2.5 |
婚姻 | 疾病治疗阶段 | ||||
无配偶 | 15 | 9.4 | 确诊未治疗 | 9 | 5.7 |
有配偶 | 144 | 90.6 | 围西医治疗期 | 127 | 79.8 |
肿瘤种类 | 随访期 | 23 | 14.5 | ||
肺癌 | 50 | 31.4 | 既往是否抗肿瘤治疗 | ||
乳腺癌 | 23 | 14.5 | 是 | 101 | 63.5 |
头颈部肿瘤 | 21 | 13.2 | 否 | 58 | 36.5 |
直肠癌 | 21 | 13.2 | 目前主要治疗方式 | ||
结肠癌 | 18 | 11.3 | 无 | 6 | 3.8 |
妇科肿瘤 | 9 | 5.7 | 化疗 | 57 | 35.8 |
胃癌 | 6 | 3.8 | 放疗 | 20 | 12.6 |
食管癌 | 3 | 1.9 | 靶向 | 12 | 7.5 |
肝癌 | 2 | 1.3 | 中医药治疗 | 64 | 40.3 |
胰腺癌 | 2 | 1.3 | KPS | ||
其他 | 4 | 2.4 | ≥80分 | 120 | 75.5 |
确诊年限 | <80分 | 39 | 24.5 | ||
<1年 | 81 | 50.9 | |||
1~3年 | 40 | 25.2 | |||
>3年 | 38 | 23.9 |
中医证候 | RPFS-CV疲乏评分(分) | ||||||
---|---|---|---|---|---|---|---|
证候 | 例(%)a | 最小值 | 最大值 | 平均值 | 下四分位数 | 中位数 | 上四分位数 |
气虚证 | 121(21.9) | 0.78 | 8.66 | 4.08 | 2.72 | 4.01 | 5.21 |
血虚证 | 46(8.3) | 1.03 | 8.67 | 4.09 | 2.40 | 3.95 | 5.56 |
阴虚证 | 25(4.5) | 1.03 | 7.93 | 3.91 | 2.54 | 3.79 | 5.27 |
阳虚证 | 18(3.3) | 1.78 | 8.08 | 3.91 | 2.71 | 3.79 | 4.71 |
脾虚证 | 60(10.8) | 1.36 | 8.67 | 4.46 | 2.79 | 4.35 | 5.54 |
肾虚证 | 54(9.8) | 1.18 | 8.66 | 4.03 | 2.43 | 3.83 | 5.33 |
肺虚证 | 50(9.0) | 0.77 | 8.66 | 3.95 | 3.05 | 3.95 | 4.76 |
心虚证 | 61(11.0) | 0.78 | 8.67 | 4.27 | 2.99 | 4.26 | 5.44 |
肝虚证 | 52(9.4) | 1.03 | 8.67 | 4.25 | 2.55 | 4.06 | 5.72 |
血瘀证 | 7(1.3) | 2.27 | 5.88 | 3.53 | 2.38 | 3.28 | 3.94 |
寒湿证 | 23(4.2) | 1.36 | 8.67 | 4.61 | 3.38 | 4.52 | 5.75 |
气滞证 | 29(5.2) | 2.16 | 8.13 | 4.48 | 2.75 | 4.38 | 5.8 |
湿热证 | 7(1.3) | 2.38 | 4.88 | 3.83 | 2.65 | 4.03 | 4.83 |
Table 2 The characteristics and fatigue scores of TCM syndromes in CRF patients
中医证候 | RPFS-CV疲乏评分(分) | ||||||
---|---|---|---|---|---|---|---|
证候 | 例(%)a | 最小值 | 最大值 | 平均值 | 下四分位数 | 中位数 | 上四分位数 |
气虚证 | 121(21.9) | 0.78 | 8.66 | 4.08 | 2.72 | 4.01 | 5.21 |
血虚证 | 46(8.3) | 1.03 | 8.67 | 4.09 | 2.40 | 3.95 | 5.56 |
阴虚证 | 25(4.5) | 1.03 | 7.93 | 3.91 | 2.54 | 3.79 | 5.27 |
阳虚证 | 18(3.3) | 1.78 | 8.08 | 3.91 | 2.71 | 3.79 | 4.71 |
脾虚证 | 60(10.8) | 1.36 | 8.67 | 4.46 | 2.79 | 4.35 | 5.54 |
肾虚证 | 54(9.8) | 1.18 | 8.66 | 4.03 | 2.43 | 3.83 | 5.33 |
肺虚证 | 50(9.0) | 0.77 | 8.66 | 3.95 | 3.05 | 3.95 | 4.76 |
心虚证 | 61(11.0) | 0.78 | 8.67 | 4.27 | 2.99 | 4.26 | 5.44 |
肝虚证 | 52(9.4) | 1.03 | 8.67 | 4.25 | 2.55 | 4.06 | 5.72 |
血瘀证 | 7(1.3) | 2.27 | 5.88 | 3.53 | 2.38 | 3.28 | 3.94 |
寒湿证 | 23(4.2) | 1.36 | 8.67 | 4.61 | 3.38 | 4.52 | 5.75 |
气滞证 | 29(5.2) | 2.16 | 8.13 | 4.48 | 2.75 | 4.38 | 5.8 |
湿热证 | 7(1.3) | 2.38 | 4.88 | 3.83 | 2.65 | 4.03 | 4.83 |
项目 | FT3(n=158) | FT4(n=158) | TSH(n=155) | T3(n=155) | T4(n=155) | Tg-Ab(n=154) | TPO-Ab(n=158) |
---|---|---|---|---|---|---|---|
气虚证 | 4.32(0.97) | 16.16(3.34) | 2.05(1.85) | 1.74(0.41) | 99.43(30.38) | 15.28(6.85) | 11.56(7.56) |
血虚证 | 4.29(0.94) | 15.85(4.77) | 2.05(1.88) | 1.70(0.43) | 98.00(32.89) | 15.80(8.15) | 12.19(8.45) |
阴虚证 | 4.02(1.37) | 15.61(4.26) | 1.40(1.59) | 1.57(0.48) | 100.90(31.37) | 17.50(30.06) | 13.10(10.58) |
阳虚证 | 4.14(0.92) | 16.93(4.46) | 3.01(2.10) | 1.69(0.35) | 102.70(31.04) | 14.18(2.93) | 9.44(8.00) |
脾虚证 | 4.18(0.92) | 16.51(3.13) | 2.07(1.71) | 1.65(0.53) | 104.10(28.33) | 14.48(9.38) | 10.74(8.46) |
肾虚证 | 4.60(0.94) | 16.51(3.14) | 2.10(1.90) | 1.77(0.51) | 100.70(29.47) | 15.64(14.16) | 11.47(8.46) |
肺虚证 | 4.32(0.87) | 16.19(3.05) | 1.41(1.76) | 1.73(0.51) | 96.76(32.44) | 15.64(6.14) | 13.1(9.69) |
心虚证 | 4.32(0.94) | 15.99(3.90) | 1.98(1.90) | 1.77(0.46) | 99.89(33.22) | 15.16(6.00) | 11.74(8.89) |
肝虚证 | 4.57(1.15) | 16.11(3.00) | 2.08(1.98) | 1.72(0.39) | 99.89(28.98) | 15.67(6.97) | 11.32(6.63) |
血瘀证 | 3.97(1.42) | 16.30(3.16) | 1.22(2.67) | 1.64(0.86) | 111.40(23.79) | 14.74(4.53) | 8.34(2.76) |
寒湿证 | 4.24(1.14) | 16.33(4.70) | 2.23(3.69) | 1.70(0.76) | 105.70(30.56) | 16.56(10.49) | 11.84(9.66) |
气滞证 | 4.58(1.01) | 17.13(3.69) | 1.82(1.04) | 1.66(0.47) | 98.22(29.46) | 15.61(7.20) | 11.88(7.59) |
湿热证 | 3.56(1.22) | 14.67(2.62) | 3.10(2.66) | 1.32(0.61) | 78.60(8.39) | 12.12(5.61) | 8.52(18.29) |
Table 3 Thyroid function level among different TCM syndromes
项目 | FT3(n=158) | FT4(n=158) | TSH(n=155) | T3(n=155) | T4(n=155) | Tg-Ab(n=154) | TPO-Ab(n=158) |
---|---|---|---|---|---|---|---|
气虚证 | 4.32(0.97) | 16.16(3.34) | 2.05(1.85) | 1.74(0.41) | 99.43(30.38) | 15.28(6.85) | 11.56(7.56) |
血虚证 | 4.29(0.94) | 15.85(4.77) | 2.05(1.88) | 1.70(0.43) | 98.00(32.89) | 15.80(8.15) | 12.19(8.45) |
阴虚证 | 4.02(1.37) | 15.61(4.26) | 1.40(1.59) | 1.57(0.48) | 100.90(31.37) | 17.50(30.06) | 13.10(10.58) |
阳虚证 | 4.14(0.92) | 16.93(4.46) | 3.01(2.10) | 1.69(0.35) | 102.70(31.04) | 14.18(2.93) | 9.44(8.00) |
脾虚证 | 4.18(0.92) | 16.51(3.13) | 2.07(1.71) | 1.65(0.53) | 104.10(28.33) | 14.48(9.38) | 10.74(8.46) |
肾虚证 | 4.60(0.94) | 16.51(3.14) | 2.10(1.90) | 1.77(0.51) | 100.70(29.47) | 15.64(14.16) | 11.47(8.46) |
肺虚证 | 4.32(0.87) | 16.19(3.05) | 1.41(1.76) | 1.73(0.51) | 96.76(32.44) | 15.64(6.14) | 13.1(9.69) |
心虚证 | 4.32(0.94) | 15.99(3.90) | 1.98(1.90) | 1.77(0.46) | 99.89(33.22) | 15.16(6.00) | 11.74(8.89) |
肝虚证 | 4.57(1.15) | 16.11(3.00) | 2.08(1.98) | 1.72(0.39) | 99.89(28.98) | 15.67(6.97) | 11.32(6.63) |
血瘀证 | 3.97(1.42) | 16.30(3.16) | 1.22(2.67) | 1.64(0.86) | 111.40(23.79) | 14.74(4.53) | 8.34(2.76) |
寒湿证 | 4.24(1.14) | 16.33(4.70) | 2.23(3.69) | 1.70(0.76) | 105.70(30.56) | 16.56(10.49) | 11.84(9.66) |
气滞证 | 4.58(1.01) | 17.13(3.69) | 1.82(1.04) | 1.66(0.47) | 98.22(29.46) | 15.61(7.20) | 11.88(7.59) |
湿热证 | 3.56(1.22) | 14.67(2.62) | 3.10(2.66) | 1.32(0.61) | 78.60(8.39) | 12.12(5.61) | 8.52(18.29) |
项目 | r值 | P值 | 项目 | r值 | P值 |
---|---|---|---|---|---|
气虚证 | 0.243 | 0.002 | 心虚证 | 0.200 | 0.012 |
血虚证 | 0.092 | 0.298 | 肝虚证 | 0.167 | 0.059 |
阴虚证 | 0.014 | 0.860 | 血瘀证 | -0.043 | 0.587 |
阳虚证 | 0.012 | 0.438 | 寒湿证 | 0.191 | 0.017 |
脾虚证 | 0.290 | <0.001 | 气滞证 | 0.181 | 0.023 |
肾虚证 | 0.075 | 0.346 | 湿热证 | -0.003 | 0.970 |
肺虚证 | 0.040 | 0.600 |
Table 4 Correlation analysis between RPFS-CV scale fatigue score and TCM syndrome
项目 | r值 | P值 | 项目 | r值 | P值 |
---|---|---|---|---|---|
气虚证 | 0.243 | 0.002 | 心虚证 | 0.200 | 0.012 |
血虚证 | 0.092 | 0.298 | 肝虚证 | 0.167 | 0.059 |
阴虚证 | 0.014 | 0.860 | 血瘀证 | -0.043 | 0.587 |
阳虚证 | 0.012 | 0.438 | 寒湿证 | 0.191 | 0.017 |
脾虚证 | 0.290 | <0.001 | 气滞证 | 0.181 | 0.023 |
肾虚证 | 0.075 | 0.346 | 湿热证 | -0.003 | 0.970 |
肺虚证 | 0.040 | 0.600 |
项目 | rs值 | P值 | 项目 | rs值 | P值 |
---|---|---|---|---|---|
FT3 | -0.237 | 0.003 | T4 | 0.082 | 0.312 |
FT4 | 0.008 | 0.920 | TG-Ab | -0.036 | 0.656 |
TSH | 0.045 | 0.575 | TPO-Ab | -0.019 | 0.813 |
T3 | -0.160 | 0.047 |
Table 5 Correlation analyses between fatigue scores and thyroid function level
项目 | rs值 | P值 | 项目 | rs值 | P值 |
---|---|---|---|---|---|
FT3 | -0.237 | 0.003 | T4 | 0.082 | 0.312 |
FT4 | 0.008 | 0.920 | TG-Ab | -0.036 | 0.656 |
TSH | 0.045 | 0.575 | TPO-Ab | -0.019 | 0.813 |
T3 | -0.160 | 0.047 |
变量 | 气虚证 | 血虚证 | 阴虚证 | 阳虚证 | 脾虚证 | 肾虚证 | 肺虚证 | 心虚证 | 肝虚证 | 血瘀证 | 寒湿证 | 气滞证 | 湿热证 | FT3 | FT4 | TSH | T3 | T4 | TG-Ab | TPO-Ab |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
气虚证 | 1.000 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
血虚证 | 0.195a | 1.000 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
阴虚证 | -0.042 | -0.009 | 1.000 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
阳虚证 | 0.014 | -0.009 | -0.154 | 1.000 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
脾虚证 | 0.010 | -0.039 | -0.158a | 0.131 | 1.000 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
肾虚证 | -0.003 | 0.187a | -0.018 | 0.205a | 0.017 | 1.000 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
肺虚证 | 0.094 | 0.016 | 0.154 | -0.156a | -0.136 | 0.001 | 1.000 | — | — | — | — | — | — | — | — | — | — | — | — | — |
心虚证 | 0.230a | 0.238a | 0.086 | 0.004 | -0.187a | 0.117 | 0.134 | 1.000 | — | — | — | — | — | — | — | — | — | — | — | — |
肝虚证 | 0.045 | 0.147 | 0.030 | 0.047 | -0.073 | 0.095 | 0.048 | 0.194a | 1.000 | — | — | — | — | — | — | — | — | — | — | — |
血瘀证 | -0.024 | -0.137 | -0.008 | -0.077 | 0.023 | -0.089 | -0.079 | -0.106 | 0.046 | 1.000 | — | — | — | — | — | — | — | — | — | — |
寒湿证 | -0.021 | -0.105 | -0.129 | 0.022 | 0.270a | 0.045 | -0.086 | 0.117 | -0.020 | -0.001 | 1.000 | — | — | — | — | — | — | — | — | — |
气滞证 | -0.041 | 0.130 | -0.070 | -0.015 | 0.136 | 0.074 | -0.039 | 0.063 | 0.122 | -0.022 | 0.130 | 1.000 | — | — | — | — | — | — | — | — |
湿热证 | -0.095 | -0.137 | 0.076 | -0.077 | -0.041 | -0.089 | -0.013 | -0.043 | -0.084 | 0.103 | -0.088 | -0.022 | 1.000 | — | — | — | — | — | — | — |
FT3 | -0.031 | -0.105 | -0.116 | 0.128 | -0.132 | -0.036 | -0.046 | 0.063 | -0.023 | -0.033 | -0.026 | -0.013 | -0.126 | 1.000 | — | — | — | — | — | — |
FT4 | 0.039 | -0.137 | -0.031 | -0.050 | -0.054 | 0.031 | -0.036 | 0.009 | -0.036 | 0.040 | -0.038 | 0.173a | -0.097 | -0.029 | 1.000 | — | — | — | — | — |
TSH | -0.136 | 0.064 | 0.003 | 0.034 | -0.112 | -0.020 | 0.135 | -0.039 | 0.093 | -0.040 | 0.022 | -0.083 | 0.065 | -0.182a | -0.285a | 1.000 | — | — | — | — |
T3 | -0.017 | -0.037 | -0.127 | -0.078 | -0.035 | 0.022 | 0.009 | 0.063 | 0.073 | 0.004 | 0.024 | -0.038 | -0.163a | 0.446a | 0.176a | -0.117 | 1.000 | — | — | — |
T4 | 0.162a | -0.011 | 0.045 | -0.001 | 0.061 | -0.029 | -0.075 | 0.125 | 0.002 | 0.080 | -0.066 | 0.083 | -0.174a | 0.079 | 0.631a | -0.160a | 0.358a | 1.000 | — | — |
TG-Ab | -0.056 | 0.132 | 0.139 | -0.082 | -0.013 | 0.069 | -0.044 | -0.018 | 0.057 | -0.060 | -0.029 | -0.026 | -0.061 | -0.022 | -0.236a | 0.065 | 0.021 | -0.143 | 1.000 | — |
TPO-Ab | 0.036 | 0.039 | 0.117 | 0.032 | 0.032 | 0.219a | -0.034 | -0.022 | 0.091 | -0.059 | 0.037 | -0.003 | -0.031 | -0.089 | -0.200a | 0.029 | -0.084 | -0.021 | 0.446a | 1.000 |
Table 6 Correlation analyses between TCM syndromes and thyroid function level
变量 | 气虚证 | 血虚证 | 阴虚证 | 阳虚证 | 脾虚证 | 肾虚证 | 肺虚证 | 心虚证 | 肝虚证 | 血瘀证 | 寒湿证 | 气滞证 | 湿热证 | FT3 | FT4 | TSH | T3 | T4 | TG-Ab | TPO-Ab |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
气虚证 | 1.000 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
血虚证 | 0.195a | 1.000 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
阴虚证 | -0.042 | -0.009 | 1.000 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
阳虚证 | 0.014 | -0.009 | -0.154 | 1.000 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
脾虚证 | 0.010 | -0.039 | -0.158a | 0.131 | 1.000 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
肾虚证 | -0.003 | 0.187a | -0.018 | 0.205a | 0.017 | 1.000 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
肺虚证 | 0.094 | 0.016 | 0.154 | -0.156a | -0.136 | 0.001 | 1.000 | — | — | — | — | — | — | — | — | — | — | — | — | — |
心虚证 | 0.230a | 0.238a | 0.086 | 0.004 | -0.187a | 0.117 | 0.134 | 1.000 | — | — | — | — | — | — | — | — | — | — | — | — |
肝虚证 | 0.045 | 0.147 | 0.030 | 0.047 | -0.073 | 0.095 | 0.048 | 0.194a | 1.000 | — | — | — | — | — | — | — | — | — | — | — |
血瘀证 | -0.024 | -0.137 | -0.008 | -0.077 | 0.023 | -0.089 | -0.079 | -0.106 | 0.046 | 1.000 | — | — | — | — | — | — | — | — | — | — |
寒湿证 | -0.021 | -0.105 | -0.129 | 0.022 | 0.270a | 0.045 | -0.086 | 0.117 | -0.020 | -0.001 | 1.000 | — | — | — | — | — | — | — | — | — |
气滞证 | -0.041 | 0.130 | -0.070 | -0.015 | 0.136 | 0.074 | -0.039 | 0.063 | 0.122 | -0.022 | 0.130 | 1.000 | — | — | — | — | — | — | — | — |
湿热证 | -0.095 | -0.137 | 0.076 | -0.077 | -0.041 | -0.089 | -0.013 | -0.043 | -0.084 | 0.103 | -0.088 | -0.022 | 1.000 | — | — | — | — | — | — | — |
FT3 | -0.031 | -0.105 | -0.116 | 0.128 | -0.132 | -0.036 | -0.046 | 0.063 | -0.023 | -0.033 | -0.026 | -0.013 | -0.126 | 1.000 | — | — | — | — | — | — |
FT4 | 0.039 | -0.137 | -0.031 | -0.050 | -0.054 | 0.031 | -0.036 | 0.009 | -0.036 | 0.040 | -0.038 | 0.173a | -0.097 | -0.029 | 1.000 | — | — | — | — | — |
TSH | -0.136 | 0.064 | 0.003 | 0.034 | -0.112 | -0.020 | 0.135 | -0.039 | 0.093 | -0.040 | 0.022 | -0.083 | 0.065 | -0.182a | -0.285a | 1.000 | — | — | — | — |
T3 | -0.017 | -0.037 | -0.127 | -0.078 | -0.035 | 0.022 | 0.009 | 0.063 | 0.073 | 0.004 | 0.024 | -0.038 | -0.163a | 0.446a | 0.176a | -0.117 | 1.000 | — | — | — |
T4 | 0.162a | -0.011 | 0.045 | -0.001 | 0.061 | -0.029 | -0.075 | 0.125 | 0.002 | 0.080 | -0.066 | 0.083 | -0.174a | 0.079 | 0.631a | -0.160a | 0.358a | 1.000 | — | — |
TG-Ab | -0.056 | 0.132 | 0.139 | -0.082 | -0.013 | 0.069 | -0.044 | -0.018 | 0.057 | -0.060 | -0.029 | -0.026 | -0.061 | -0.022 | -0.236a | 0.065 | 0.021 | -0.143 | 1.000 | — |
TPO-Ab | 0.036 | 0.039 | 0.117 | 0.032 | 0.032 | 0.219a | -0.034 | -0.022 | 0.091 | -0.059 | 0.037 | -0.003 | -0.031 | -0.089 | -0.200a | 0.029 | -0.084 | -0.021 | 0.446a | 1.000 |
[1] |
NCCN Clinical Practice Guidelines in Oncology(NCCN Guidelines?). Cancer-Related Fatigue Version 2[EB/OL].(2023-01-30)[2023-07-31].
|
[2] |
|
[3] |
栗琼洋. 结直肠癌患者癌因性疲乏的证候特征和相关因素分析[D]. 北京:北京中医药大学,2019.
|
[4] |
|
[5] |
董景五. 疾病和有关健康问题的国际统计分类第十次修订本[M]. 北京:人民卫生出版社,2008.
|
[6] |
|
[7] |
郑筱萸. 中药新药临床研究指导原则:试行[M]. 北京:中国医药科技出版社,2002.
|
[8] |
|
[9] |
吴辉渊,郭红飞,徐婷,等. 热敏灸干预对中晚期肺癌患者癌因性疲乏的作用[J]. 针灸临床杂志,2016,32(7):52-54. DOI:10.19917/j.cnki.1005-0779.2016.07.019.
|
[10] |
|
[11] |
|
[12] |
谷珊珊. 癌因性疲乏的证候特征及相关影响因素的研究[D]. 北京:中国中医科学院,2022.
|
[13] |
单忠艳,滕卫平,李玉姝,等. 碘致甲状腺功能减退症的流行病学对比研究[J]. 中华内分泌代谢杂志,2001,17(2):11-14. DOI:10.3760/j.issn:1000-6699.2001.02.003.
|
[14] |
刘丽星,常金圆,李沛瑾,等. 肿瘤湿热证病证分布规律探析[J]. 天津中医药,2021,38(10):1282-1287.
|
[15] |
佟丽,吴仕九. 湿热证患者免疫功能及自由基水平变化的研究[J]. 中国实验临床免疫杂志,1999,11(4):48-50.
|
[16] |
[1] | TU Shuting, LIN Jiaying, ZHUANG Jinyang, XIANG Jingnan, WEI Dongshuai, XIE Yong, JIA Jie. Incidence and Related Factors of Post-stroke Cognitive Impairment: a Multicenter Cross-sectional Study Based on Full-cycle Rehabilitation in Stroke [J]. Chinese General Practice, 2024, 27(23): 2829-2837. |
[2] | LI Xueying, KANG Xiaoping, CHI Chunhua, WANG Xicheng, SHANG Meixia, ZHOU Guopeng, GAO Chang, PAN Zihan. Basic Design and Implementation Steps for Cross-sectional Studies in General Practice and Primary Care [J]. Chinese General Practice, 2024, 27(13): 1584-1593. |
[3] | ZHOU Yujie, LIU Huanting, WAN Chonghua, GAN Qihui, XIAO Junhui, LIU Yuxi. Research on the Relationship between Well-being and Personality Traits in the Elderly Based on Canonical Correlation Analysis [J]. Chinese General Practice, 2024, 27(08): 955-960. |
[4] | LUO Weigang, YIN Yuanyuan, LIU Wanhu, XU Yuzhu, CAO Xiaoyun, BU Wei, ZHANG Lingyan, REN Huiling. Correlation of Triglyceride Glucose Index with Early Neurological Deterioration in Patients with Single Subcortical Infarction [J]. Chinese General Practice, 2023, 26(35): 4419-4424. |
[5] | CHEN Weixiang, YIN Renlin, LING Lin, ZHANG Chi, JIANG Tingbo, LIN Jia. Correlation between C-reactive Protein to Albumin and Coronary Collateral Circulation in Patients with Unstable Angina Pectoris [J]. Chinese General Practice, 2023, 26(27): 3430-3434. |
[6] | ZUMURETI ·Abudukeyimu, MA Yanlin, ZHU Kairui, LIU Fang, LI Xia. Correlation of Early Growth Response 3 and Interleukin 6 Expression Levels with Coronary Heart Disease [J]. Chinese General Practice, 2023, 26(24): 3016-3021. |
[7] | ZHOU Shiyu, CHEN Shaolin, DENG Renli, DAI Mi, LIU Tao, TIAN Kunming. The Association and Predictive Value of Lipid Ratios to Metabolic Syndrome: a Multistage Cross-sectional Study [J]. Chinese General Practice, 2023, 26(21): 2589-2596. |
[8] | DING Xiaoyun, JIN Juzhen, YANG Jin, ZHOU Jing, HU Jin, MENG Yue, LIANG Xiaoxian, GAI Yun, WANG Junhua, WANG Ziyun. The Mediating Effect of Waist Circumference and Fasting Plasma Glucose on the Association between Obstructive Sleep Apnea Syndrome and Arterial Stiffness in a Population Aged 40-65 Years [J]. Chinese General Practice, 2023, 26(21): 2597-2602. |
[9] | XU Bixia, YAO Weiguang. Changes in Patient Visits and Associated Determinants in Primary Healthcare Settings in Guangdong: a Grey Relational Analysis [J]. Chinese General Practice, 2023, 26(16): 1965-1971. |
[10] | DONG Linrui, CHANG Qingqing, MA Jianjun, LIU Chuanze, GUO Dashuai, LI Xiaohuan, FAN Yongyan, LI Dongsheng. Correlation between Autonomic Dysfunction and Cognitive Impairment in Patients with Parkinson's Disease [J]. Chinese General Practice, 2023, 26(12): 1450-1455. |
[11] | Anbang LIU, Cheng JIANG, Han YIN, Huan MA, Qingshan GENG. Association between Free Triiodothyronine and Depression in Patients with Coronary Heart Disease [J]. Chinese General Practice, 2022, 25(14): 1707-1712. |
[12] | HU Ruidan,ZHOU Hongzhen,LIU Zhihong,HOU Jiakun,LIU Yangyang,BAI Xuejie,LI Muling. Correlation between Stigma and Post-stroke Depression in Initally Diagnosed Stroke Patients [J]. Chinese General Practice, 2021, 24(6): 727-731. |
[13] | GAO Suying,YAN Yinglin,YU Kai,ZHANG Guangbo,JI Ruijun,WANG Yongjun,LI Fang,ZHANG Na,ZHU Donglei. Risk Factors of Carotid Atherosclerosis in Patients with Acute Ischemic Stroke [J]. Chinese General Practice, 2021, 24(3): 327-332. |
[14] | LI Zhouhua,JI Shuang,HU Xianwei,YOU Qinghai,FEI Guanghe. Analysis of Risk Factors of Lung Cancer Patients Combined with Sarcopenia and Their Correlation with Clinical Prognosis [J]. Chinese General Practice, 2021, 24(26): 3310-3315. |
[15] | LI Qian,ZHAO Jianhua,PENG Xue,MENG Lifang,LIU Hao,WANG Jin,LIU Junli,ZHAO Panpan,WANG Fan,LI Shaomin. Serum Uric Acid Level and Mild Cognitive Impairment in Patients with H-type Hypertension [J]. Chinese General Practice, 2021, 24(20): 2527-2531. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||